| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Ambrx Biopharma Inc. | 10%+ Owner | Ordinary Shares | 69.5M | $642M | $9.24 | 18 Sep 2023 | Indirect |
| EyePoint Pharmaceuticals, Inc. | Former 10% Owner | Common Stock | 8.27M | $130M | $15.70 | 04 Dec 2025 | Indirect |
| Ambrx Biopharma, Inc. | 10%+ Owner | Common Stock | 11.2M | $110M | $9.82 | 23 Oct 2023 | Indirect |
| Monte Rosa Therapeutics, Inc. | Former 10% Owner | Common Stock | 3.2M | $60.8M | $19.00 | 28 Jun 2021 | Indirect |
| Aerovate Therapeutics, Inc. | Former 10% Owner | Common Stock | 2.03M | $39.6M | $19.50 | 02 Jul 2021 | Indirect |
| BioAge Labs, Inc. | Former 10% Owner | Common Stock | 1.63M | $29.3M | $18.00 | 27 Sep 2024 | Indirect |
| Corbus Pharmaceuticals Holdings, Inc. | 10%+ Owner | Common Stock | 2.34M | $26.9M | $11.46 | 11 Dec 2025 | Indirect |
| Verve Therapeutics, Inc. | Former 10% Owner | Common Stock | 984K | $9.84M | $10.00 | 21 Jun 2021 | Indirect |
| Immuneering Corp | 10%+ Owner | Class A Common Stock | 2.9M | $8.6M | $2.97 | 01 Apr 2024 | Indirect |
| Tyra Biosciences, Inc. | Former 10% Owner | Common Stock | 1.07M | $7.04M | $6.58 | 17 Sep 2021 | Indirect |
| Icosavax, Inc. | Former 10% Owner | Common Stock | 426K | $6.68M | $15.67 | 02 Aug 2021 | Indirect |
| Ventyx Biosciences, Inc. | Former 10% Owner | Common Stock | 1.41M | $2.99M | $2.12 | 25 Oct 2021 | Indirect |
| Vigil Neuroscience, Inc. | Former 10% Owner | Common Stock | 617K | $2.31M | $3.75 | 11 Jan 2022 | Indirect |
| Pyxis Oncology, Inc. | Former 10% Owner | Common Stock | 1.12M | $1.57M | $1.40 | 13 Oct 2021 | Indirect |
| Elevation Oncology, Inc. | Former 10% Owner | Common Stock | 2.23M | $1.14M | $0.51 | 29 Jun 2021 | Indirect |
| OnKure Therapeutics, Inc. | Former 10% Owner | Class A Common Stock | 0 | $0 | $1.85 | 15 May 2025 | Indirect |
| BRIGHT MINDS BIOSCIENCES INC. | 10%+ Owner | Common Shares | 1.06M | 04 Nov 2024 | Indirect | ||
| Aardvark Therapeutics, Inc. | Former 10% Owner | Common Stock | 988K | 14 Feb 2025 | Indirect | ||
| Aardvark Therapeutics, Inc. | Former 10% Owner | Series C Convertible Preferred Stock | 0 | 14 Feb 2025 | Indirect | ||
| Aerovate Therapeutics, Inc. | Former 10% Owner | Series A Convertible Preferred Stock | 0 | 02 Jul 2021 | Indirect | ||
| BioAge Labs, Inc. | Former 10% Owner | Series D Redeemable Convertible Preferred Stock | 0 | 27 Sep 2024 | Indirect | ||
| Elevation Oncology, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | 29 Jun 2021 | Indirect | ||
| GreenLight Biosciences Holdings, PBC | Other* | Common Stock | 0 | $0.30 | 20 Jul 2023 | Indirect | |
| Icosavax, Inc. | Former 10% Owner | Series B-1 Convertible Preferred Stock | 0 | 02 Aug 2021 | Indirect | ||
| Monte Rosa Therapeutics, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | $2.00 | 28 Jun 2021 | Indirect | |
| Monte Rosa Therapeutics, Inc. | Former 10% Owner | Series C Convertible Preferred Stock | 0 | 28 Jun 2021 | Indirect | ||
| Pyxis Oncology, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | 13 Oct 2021 | Indirect | ||
| Tyra Biosciences, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | 17 Sep 2021 | Indirect | ||
| Ventyx Biosciences, Inc. | Former 10% Owner | Series A Convertible Preferred Stock | 0 | 25 Oct 2021 | Indirect | ||
| Ventyx Biosciences, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | 25 Oct 2021 | Indirect | ||
| Verve Therapeutics, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | 21 Jun 2021 | Indirect | ||
| Vigil Neuroscience, Inc. | Former 10% Owner | Series B Convertible Preferred Stock | 0 | 11 Jan 2022 | Indirect |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 11 Dec 2025 | 1 | -$344K | 4 | 10%+ Owner | 15 Dec 2025, 16:18 |
| EYPT | EyePoint, Inc. | 04 Dec 2025 | 1 | -$942K | 4 | Former 10% Owner | 08 Dec 2025, 16:03 |
| OKUR | OnKure Therapeutics, Inc. | 15 May 2025 | 1 | -$3.36M | 4 | Former 10% Owner | 19 May 2025, 17:33 |
| OKUR | OnKure Therapeutics, Inc. | 12 May 2025 | 1 | -$48.2K | 4 | 10%+ Owner | 14 May 2025, 16:36 |
| AARD | Aardvark Therapeutics, Inc. | 14 Feb 2025 | 3 | $3M | 4 | Former 10% Owner | 19 Feb 2025, 16:02 |
| AARD | Aardvark Therapeutics, Inc. | 12 Feb 2025 | 0 | $0 | 3 | 10%+ Owner | 12 Feb 2025, 17:18 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 04 Nov 2024 | 1 | $4M | 4 | 10%+ Owner | 06 Nov 2024, 16:20 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 15 Oct 2024 | 11 | $3.23M | 4 | 10%+ Owner | 17 Oct 2024, 17:11 |
| DRUG | BRIGHT MINDS BIOSCIENCES INC. | 15 Oct 2024 | 0 | $0 | 3 | 10%+ Owner | 17 Oct 2024, 17:07 |
| OKUR | OnKure Therapeutics, Inc. | 04 Oct 2024 | 0 | $0 | 3 | 10%+ Owner | 15 Oct 2024, 16:08 |
| BIOA | BioAge Labs, Inc. | 27 Sep 2024 | 3 | $8.1M | 4 | Former 10% Owner | 01 Oct 2024, 16:01 |
| BIOA | BioAge Labs, Inc. | 25 Sep 2024 | 0 | $0 | 3 | 10%+ Owner | 25 Sep 2024, 18:43 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 20 Sep 2024 | 6 | $7M | 4 | 10%+ Owner | 24 Sep 2024, 16:04 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 06 May 2024 | 2 | $10.1M | 4 | 10%+ Owner | 08 May 2024, 16:23 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 18 Apr 2024 | 2 | $10.5M | 4 | 10%+ Owner | 22 Apr 2024, 16:00 |
| IMRX | Immuneering Corp | 01 Apr 2024 | 8 | -$1.16M | 4 | 10%+ Owner | 03 Apr 2024, 17:37 |
| IMRX | Immuneering Corp | 14 Mar 2024 | 5 | -$2.75M | 4 | 10%+ Owner | 18 Mar 2024, 17:59 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 07 Mar 2024 | 10 | $23.3M | 4 | 10%+ Owner | 11 Mar 2024, 17:34 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 02 Feb 2024 | 1 | $14.3M | 4 | 10%+ Owner | 06 Feb 2024, 16:00 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 26 Jan 2024 | 14 | $9.11M | 4 | 10%+ Owner | 30 Jan 2024, 16:23 |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 26 Jan 2024 | 0 | $0 | 3 | 10%+ Owner | 30 Jan 2024, 16:18 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 09 Jan 2024 | 2 | $17.1M | 4 | 10%+ Owner | 11 Jan 2024, 16:00 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 08 Dec 2023 | 1 | $10M | 4 | 10%+ Owner | 12 Dec 2023, 16:52 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 04 Dec 2023 | 17 | $41.9M | 4 | 10%+ Owner | 06 Dec 2023, 16:39 |
| EYPT | EyePoint Pharmaceuticals, Inc. | 04 Dec 2023 | 0 | $0 | 3 | 10%+ Owner | 06 Dec 2023, 16:38 |
| AMAM | Ambrx Biopharma, Inc. | 23 Oct 2023 | 1 | $9.14M | 4 | 10%+ Owner | 25 Oct 2023, 16:15 |
| AMAM | Ambrx Biopharma Inc. | 15 Sep 2023 | 2 | $19.6M | 4 | 10%+ Owner | 19 Sep 2023, 16:49 |
| GRNA | GreenLight Biosciences Holdings, PBC | 20 Jul 2023 | 1 | $0 | 4 | Other* | 24 Jul 2023, 16:01 |
| GRNA | GreenLight Biosciences Holdings, PBC | 29 May 2023 | 0 | $0 | 3 | Other* | 08 Jun 2023, 17:12 |
| IMRX | Immuneering Corp | 20 Apr 2023 | 0 | $0 | 3 | 10%+ Owner | 24 Apr 2023, 17:21 |
| AMAM | Ambrx Biopharma Inc. | 18 Apr 2023 | 3 | $59M | 4 | 10%+ Owner | 20 Apr 2023, 18:04 |
| AMAM | Ambrx Biopharma Inc. | 13 Apr 2023 | 3 | $25.3M | 4 | 10%+ Owner | 17 Apr 2023, 17:46 |
| AMAM | Ambrx Biopharma Inc. | 14 Mar 2023 | 3 | $10.2M | 4 | 10%+ Owner | 16 Mar 2023, 18:04 |
| AMAM | Ambrx Biopharma Inc. | 03 Mar 2023 | 0 | $0 | 3 | 10%+ Owner | 13 Mar 2023, 16:01 |
| VIGL | Vigil Neuroscience, Inc. | 11 Jan 2022 | 2 | $0 | 4 | Former 10% Owner | 13 Jan 2022, 15:06 |
| VIGL | Vigil Neuroscience, Inc. | 06 Jan 2022 | 0 | $0 | 3 | 10%+ Owner | 06 Jan 2022, 15:28 |
| VTYX | Ventyx Biosciences, Inc. | 25 Oct 2021 | 4 | $10M | 4 | Former 10% Owner | 27 Oct 2021, 16:04 |
| VTYX | Ventyx Biosciences, Inc. | 20 Oct 2021 | 0 | $0 | 3 | 10%+ Owner | 20 Oct 2021, 17:19 |
| PYXS | Pyxis Oncology, Inc. | 13 Oct 2021 | 3 | $7.2M | 4 | Former 10% Owner | 15 Oct 2021, 16:12 |
| PYXS | Pyxis Oncology, Inc. | 07 Oct 2021 | 0 | $0 | 3 | 10%+ Owner | 07 Oct 2021, 17:05 |
| TYRA | Tyra Biosciences, Inc. | 17 Sep 2021 | 3 | $5M | 4 | Former 10% Owner | 21 Sep 2021, 16:03 |
| TYRA | Tyra Biosciences, Inc. | 14 Sep 2021 | 0 | $0 | 3 | 10%+ Owner | 14 Sep 2021, 16:35 |
| IMRX | Immuneering Corp | 03 Aug 2021 | 3 | $8.25M | 4 | Former 10% Owner | 05 Aug 2021, 16:01 |
| ICVX | Icosavax, Inc. | 02 Aug 2021 | 2 | $0 | 4 | Former 10% Owner | 04 Aug 2021, 16:02 |
| IMRX | Immuneering Corp | 29 Jul 2021 | 0 | $0 | 3 | 10%+ Owner | 29 Jul 2021, 16:54 |
| ICVX | Icosavax, Inc. | 28 Jul 2021 | 0 | $0 | 3 | 10%+ Owner | 28 Jul 2021, 16:24 |
| AVTE | Aerovate Therapeutics, Inc. | 02 Jul 2021 | 3 | $7M | 4 | Former 10% Owner | 07 Jul 2021, 16:45 |
| ELEV | Elevation Oncology, Inc. | 29 Jun 2021 | 3 | $4M | 4 | Former 10% Owner | 01 Jul 2021, 16:24 |
| AVTE | Aerovate Therapeutics, Inc. | 29 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 29 Jun 2021, 17:09 |
| GLUE | Monte Rosa Therapeutics, Inc. | 28 Jun 2021 | 4 | $11.4M | 4 | Former 10% Owner | 30 Jun 2021, 16:08 |
| ELEV | Elevation Oncology, Inc. | 24 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 24 Jun 2021, 17:14 |
| GLUE | Monte Rosa Therapeutics, Inc. | 23 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 23 Jun 2021, 18:09 |
| VERV | Verve Therapeutics, Inc. | 21 Jun 2021 | 3 | $5.23M | 4 | Former 10% Owner | 23 Jun 2021, 16:02 |
| VERV | Verve Therapeutics, Inc. | 16 Jun 2021 | 0 | $0 | 3 | 10%+ Owner | 16 Jun 2021, 16:55 |